EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comorbidities Are Associated With Unfavorable Outcome in Aquaporin‐4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: Exploratory Study From the CROCTINO Cohort

Sara Samadzadeh iD, Frederike Cosima Oertel, Hadi Salih, Ting-Yi Lin, Seyedamirhosein Motamedi, Claudia Chien, Lawrence J Cook, Marco Aurélio Lana-Peixoto, Mariana Andrade Fontenelle, Ho Jin Kim iD, Jae-Won Hyun, Su-Kyung Jung und 48 weitere

European Journal of Neurology · 2025

DOI: 10.1111/ene.70214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Neurology, 2025. Verfasst von Sara Samadzadeh und 59 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark. Hauptthemen laut MEDLINE: Aquaporin 4, Autoantibodies, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease, Neuromyelitis Optica. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Lundbeck Foundation, the University of Southern Denmark, the Slagelse Hospital Research Fund, the Region Zealand Health Sciences Research Fund, the Guthy-Jackson Charitable Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Comorbidities occur in aquaporin‐4 antibody‐positive neuromyelitis optica spectrum disorder (AQP4‐NMOSD), myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD), and double seronegative NMOSD (DN‐NMOSD), potentially contributing to a less favorable disease course.

Objectives

To characterize comorbidities in AQP4‐NMOSD, MOGAD, and DN‐NMOSD and assess their association with optic neuritis (ON) outcomes by optical coherence tomography (OCT) in AQP4‐NMOSD.

Methods

Four hundred and forty‐two participants from the CROCTINO cohort were evaluated for comorbidities.

Results

In AQP4‐NMOSD patients ( n = 360), 43.5% ( n = 161) had comorbidities, equally divided between single and multiple. In MOGAD ( n = 49), 40.8% had comorbidities, with 75% ( n = 15) single and 25% ( n = 5) multiple. In DN‐NMOSD ( n = 33), 36.4% ( n = 12) had comorbidities equally split. AQP4‐NMOSD patients had more multiple comorbidities (50%, n = 81/161) than MOGAD (25%, n = 5/20, p = 0.03) and more autoimmune disorders (AID) (40.4%, n = 65) than MOGAD (20%, n = 4, p = 0.09) and DN‐NMOSD (none, p = 0.004). Cardiovascular comorbidities and related risk factors (CVC/RF) occurred in 34.8% ( n = 56) of AQP4‐NMOSD, 50% ( n = 10) of MOGAD, and 33.3% ( n = 4) of DN‐NMOSD. Expanded Disability Status Scale was higher in MOGAD (3.0 vs. 2.0, p = 0.006) and DN‐NMOSD (5.0 vs. 2.0, p = 0.008) with comorbidities. AQP4‐NMOSD patients with CVC/RF had higher ON relapse rates than those with AID (1.06 ± 3.33 vs. 0.49 ± 0.98, p < 0.001). OCT revealed reduced inner nuclear layer thickness in AQP4‐NMOSD with comorbidities compared to non‐comorbidity ( B = −1.52, p = 0.047), more pronounced with CVC/RF ( B = −2.96, p = 0.009).

Conclusion

Comorbidities are frequent in AQP4‐NMOSD and MOGAD and are associated with ON frequency and disability. These findings highlight the need for proactive comorbidity management to improve patient care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aquaporin 4AutoantibodiesMyelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseNeuromyelitis OpticaAdultFemaleHumansMaleMiddle AgedYoung AdultCohort StudiesComorbidityMyelin-Oligodendrocyte GlycoproteinOptic NeuritisTomography, Optical Coherence

Stichwörter der Autor:innen

anti‐aquaporin‐4 (AQP4)anti‐myelin oligodendrocyte glycoprotein antibody‐associated diseasecomorbiditydouble‐seronegative NMOSDneuromyelitis optica spectrum disorderoptical coherence tomography

Substanzen

AQP4 protein, humanAquaporin 4AutoantibodiesMyelin-Oligodendrocyte Glycoprotein

Autor:innen und Institutionen

  • Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  • The Center for Neurological Research, Department of Neurology Slagelse Hospitals, Slagelse, Denmark.
  • Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine and Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Ge…
  • Max Delbrück Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany.
  • Neuroscience Clinical Research Center, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Department of Neurology, Johns Hopkins Hospital, Baltimore, Maryland, USA.

ORCID-Profile: Sara Samadzadeh, Ho Jin Kim, Adriana Roca-Fernandez, Marco Pisa, Elena H Martinez-Lapiscina, Sasitorn Siritho, Joachim Havla, Ivan Maynart Tavares, Uygur Tanriverdi

Förderung

  • the Lundbeck Foundation
  • the University of Southern Denmark, the Slagelse Hospital Research Fund, the Region Zealand Health Sciences Research Fund
  • the Guthy-Jackson Charitable Foundation

Zitieren

APA

Samadzadeh, S., Oertel, F. C., Salih, H., Lin, T. Y., Motamedi, S., Chien, C., Cook, L. J., Lana-Peixoto, M. A., Fontenelle, M. A., Kim, H. J., Hyun, J. W., Jung, S. K., Palace, J., Roca-Fernandez, A., Leite, M. I., Sharma, S. M., Ashtari, F., Kafieh, R., Dehghani, A., …, & Brandt, A. U. (2025). Comorbidities Are Associated With Unfavorable Outcome in Aquaporin‐4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: Exploratory Study From the CROCTINO Cohort. European Journal of Neurology. https://doi.org/10.1111/ene.70214

Vancouver

Samadzadeh S, Oertel FC, Salih H, Lin TY, Motamedi S, Chien C, et al. Comorbidities Are Associated With Unfavorable Outcome in Aquaporin‐4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: Exploratory Study From the CROCTINO Cohort. European Journal of Neurology. 2025. doi:10.1111/ene.70214

BibTeX
@article{Samadzadeh2025,
  author = {Samadzadeh, Sara and Oertel, Frederike Cosima and Salih, Hadi and Lin, Ting-Yi and Motamedi, Seyedamirhosein and Chien, Claudia and Cook, Lawrence J and Lana-Peixoto, Marco Aurélio and Fontenelle, Mariana Andrade and Kim, Ho Jin and Hyun, Jae-Won and Jung, Su-Kyung and Palace, Jaqueline and Roca-Fernandez, Adriana and Leite, Maria Isabel and Sharma, Srilakshmi M and Ashtari, Fereshteh and Kafieh, Rahele and Dehghani, Alireza and Pourazizi, Mohsen and Pandit, Lekha and Dcunha, Anitha and Aktas, Orhan and Ringelstein, Marius and Albrecht, Philipp and May, Eugene F and Tongco, Caryl and Leocani, Letizia and Pisa, Marco and Radaelli, Marta and Sánchez-Dalmau, Bernardo and Martinez-Lapiscina, Elena H and Stiebel-Kalish, Hadas and Hellmann, Mark A and Lotan, Itay and Siritho, Sasitorn and de Seze, Jérôme and Senger, Thomas and Havla, Joachim and Marignier, Romain and Tilikete, Caroline Froment and Cobo-Calvo, Alvaro and Bichuetti, Denis and Tavares, Ivan Maynart and Soelberg, Kerstin and Altintas, Ayse and Yildirim, Rengin and Tanriverdi, Uygur and Jacob, Anu and Huda, Saif and Rimler, Zoe and Reid, Allyson and Mao-Draayer, Yang and Villoslada, Pablo and de Castillo, Ibis Soto and Green, Ari and Petzold, Axel and Yeaman, Michael R and Smith, Terry J and Brandt, Alexander U},
  title = {Comorbidities Are Associated With Unfavorable Outcome in Aquaporin‐4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease: Exploratory Study From the CROCTINO Cohort},
  journal = {European Journal of Neurology},
  year = {2025},
  doi = {10.1111/ene.70214}
}
Kostenlos starten →